2 Profitable Stocks to Consider Right Now and 1 We Question [Yahoo! Finance]
Collegium Pharmaceutical, Inc. (COLL)
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.collegiumpharma.com
Company Research
Source: Yahoo! Finance
Not all profitable companies are created equal, and that's why we built StockStory - to help you find the ones that truly shine bright. Keeping that in mind, here are two profitable companies that balance growth and profitability and one that may struggle to keep up. One Stock to Sell: Collegium Pharmaceutical (COLL) Trailing 12-Month GAAP Operating Margin: 23% Pioneering abuse-deterrent technology in a field plagued by addiction concerns, Collegium Pharmaceutical (NASDAQ:COLL) develops and markets specialty medications for treating moderate to severe pain, including abuse-deterrent opioid formulations. Why Are We Hesitant About COLL? Modest revenue base of $780.6 million gives it less fixed cost leverage and fewer distribution channels than larger companies Day-to-day expenses have swelled relative to revenue over the last two years as its adjusted operating margin fell by 4.8 percentage points Diminishing returns on capital suggest its earlier profit pools are dryin
Show less
Read more
Impact Snapshot
Event Time:
COLL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COLL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COLL alerts
High impacting Collegium Pharmaceutical, Inc. news events
Weekly update
A roundup of the hottest topics
COLL
News
- 1 Value Stock on Our Buy List and 2 Facing Headwinds [Yahoo! Finance]Yahoo! Finance
- Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug Manufacturers [Yahoo! Finance]Yahoo! Finance
- Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD [Yahoo! Finance]Yahoo! Finance
- Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) [Yahoo! Finance]Yahoo! Finance
- Collegium Pharmaceutical (COLL) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $56.00 price target on the stock, up from $54.00.MarketBeat
COLL
Earnings
- 2/26/26 - Beat
COLL
Sec Filings
- 4/3/26 - Form 4
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form 4
- COLL's page on the SEC website